The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control
NCT ID: NCT04399460
Last Updated: 2025-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
93 participants
INTERVENTIONAL
2020-09-01
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Full-fat Dairy Products, Body Weight Control and Metabolic Health
NCT05417347
Dairy and Vegan Cheese: Effect on Satiety and Blood Glucose
NCT06568497
The Effects of Dairy Products on Energy Balance
NCT01199835
Form of Dairy Products on Satiety, Food Intake and Post-meal Glycaemia in Young and Older Adults
NCT02491801
Milk Fat Intake and Metabolic Health Markers
NCT02659748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the beginning and after 12 weeks, body weight, composition will be measured through Bodpod scans. Resting metabolic rate and thermogenesis will be measured by indirect calorimetry. Also, fecal samples will be collected for gut microbiome profiling along with blood for glucose, insulin, hormones, triacylglycerol, HbA1c, short-chain fatty acid, red blood cells and FGF21. Urine samples will be collected throughout the study.
A followup session at 16 weeks will reassess previous measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Dairy Energy Restrictive Diet
Low-dairy (\<1 serving/day) and 500kcal/deficit per day energy restrictive diet
Restrictive Eating
Dietitian will assist with 500 kcal/day reduction through limiting of macronutrients 45-65% energy from carbohydrates 20-35% energy from fat 10-35% energy from protein
3 Servings of Full-Fat Dairy with Energy Restrictive diet
Energy-restrictive diet (500 kcal/deficit per day) with 3 servings of full-fat dairy products from full-fat milk, and assorted yogurts and cheeses
Dairy-based commercially available food products
Full-fat milk (3.25% milk, 250 mL), assortment of yogurts, and cheeses
Restrictive Eating
Dietitian will assist with 500 kcal/day reduction through limiting of macronutrients 45-65% energy from carbohydrates 20-35% energy from fat 10-35% energy from protein
3 Servings of Full-Fat Dairy but no energy restriction
Normal diet (no energy restriction) with 3 servings of full-fat dairy products from full-fat milk, and assorted yogurts and cheeses
Dairy-based commercially available food products
Full-fat milk (3.25% milk, 250 mL), assortment of yogurts, and cheeses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dairy-based commercially available food products
Full-fat milk (3.25% milk, 250 mL), assortment of yogurts, and cheeses
Restrictive Eating
Dietitian will assist with 500 kcal/day reduction through limiting of macronutrients 45-65% energy from carbohydrates 20-35% energy from fat 10-35% energy from protein
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fasting serum glucose: ≤ 7 mmol/L
* Low ≤1 serving of dairy consumption
* Waist circumference \>88cm (women) and \>102cm (men)
* Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
* Willing to maintain current dietary supplement use throughout the trial. On test days, participant agrees not to take any dietary supplements until dismissal from the study. Failure to comply will result in a rescheduled test visit.
* Willing to abstain from alcohol consumption for 24 h prior to all test visits.
* Willing to avoid vigorous physical activity for 24 h prior to all test visits.
* Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator
Exclusion Criteria
* Triglycerides ≥ 2.3 mmol/L
* Smoking tobacco products and marijuana
* Thyroid problems
* Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorptive syndrome, pancreatitis, gallbladder or biliary disease.
* Presence of gastrointestinal disorder or surgeries within the past year.
* Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgement.
* Known to be pregnant or lactating, or planning on becoming pregnant in the next 12 months.
* Irregular menstrual cycles (i.e. frequent missed cycles), menopausal or post- menopausal
* Unwillingness or inability to comply with the experimental procedures
* Known intolerance, sensitivity or allergy to dairy products
* Consumption of protein powders/protein supplements
* Extreme dietary habits
* Uncontrolled hypertension as defined by the average blood pressure measured at screening.
* Weight gain or loss of at least 10 lbs in previous three months, and history of childhood overweight or obesity
* Excessive alcohol intake
* Restrained Eaters
30 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mount Saint Vincent University
OTHER
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
G. Harvey Anderson
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
G. Harvey Anderson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Saint Vincent University
Halifax, Nova Scotia, Canada
Department of Nutritional Sciences
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DFC_LTDairy_2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.